Glypican-3 vaccine as an adjuvant therapy for hepatocellular carcinoma patients can prolong their overall survival

被引：0
|
作者：
Taniguchi, Masatake [1 ]
Sawada, Yu [2 ]
Yoshikawa, Toshiaki [2 ]
Mizuno, Shoichi [2 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] Kumamoto Univ, Grad Sch, Dept Med Oncol & Translat Res, Div Canc Immunotherapy,Natl Canc Ctr, Kumamoto, Japan
[2] Kumamoto Univ, Natl Canc Ctr, Div Canc Immunotherapy, Kumamoto, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3205
引用
收藏
页码：1333 / 1333
页数：1
相关论文
共 50 条
  • [1] Evaluation of glypican-3 in patients with hepatocellular carcinoma
    Batbaatar, Batchimeg
    Gurbadam, Unenbat
    Tuvshinsaikhan, Odonchimeg
    Narmandakh, Nyam-Erdene
    Khatanbaatar, Gerelee
    Radnaabazar, Munkhbat
    Erdene-Ochir, Dulguun
    Boldbaatar, Minjuur
    Byambaragchaa, Munkhdelger
    Amankyeldi, Yerbolat
    Chogsom, Munkhzaya
    Ganbileg, Nyamsuren
    Batdelger, Amgalantuul
    Demchig, Tserendorj
    Nyam-Osor, Lkham
    Bayartugs, Batsaikhan
    Batmunkh, Enkhtsatsral
    Munkhjargal, Batkhishig
    Lonjid, Tulgaa
    Khasbagana, Batbayar
    Batmunkh, Munkhbat
    Jav, Sarantuya
    Semchin, Munkhbayar
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (01)
  • [2] Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
    Tsuchiya, Nobuhiro
    Yoshikawa, Toshiaki
    Fujinami, Norihiro
    Saito, Keigo
    Mizuno, Shoichi
    Sawada, Yu
    Endo, Itaru
    Nakatsura, Tetsuya
    ONCOIMMUNOLOGY, 2017, 6 (10):
  • [3] A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma
    Wu, Qunfeng
    Pi, Liya
    Le, Trinh Thu
    Xia, Chang Qing
    Liu, Chen
    HEPATOLOGY, 2017, 66 : 973A - 973A
  • [4] A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma
    Wu, Qunfeng
    Pi, Liya
    Thu Le Trinh
    Zuo, Chaohui
    Xia, Man
    Jiao, Yu
    Hou, Zhouhua
    Jo, Sung
    Puszyk, William
    Pham, Kien
    Nelson, David R.
    Robertson, Keith
    Ostrov, David
    Rameshwar, Pranela
    Xia, Chang Qing
    Liu, Chen
    MOLECULAR THERAPY, 2017, 25 (10) : 2299 - 2308
  • [5] Phase I Clinical Trial of Glypican-3 Peptide Vaccine in Patients with Hepatocellular Carcinoma
    Nakatsura, Tetsuya
    Yoshikawa, Toshiaki
    Kuronuma, Toshimitsu
    Shirakawa, Hirofumi
    Hayashi, Emiko
    Nishimura, Yoshiko
    Tsuchihara, Masami
    Motomura, Yutaka
    TUMOR BIOLOGY, 2008, 29 : 22 - 22
  • [6] Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
    Couzinet, Arnaud
    Suzuki, Toshihiro
    Nakatsura, Tetsuya
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (10) : 895 - 909
  • [7] Immunological efficacy of glypican-3 (GPC3) peptide vaccine in patients with advanced hepatocellular carcinoma
    Tsuchiya, Nobuhiro
    Yoshikawa, Toshiaki
    Fujinami, Norihiro
    Saito, Keigo
    Shimomura, Manami
    Suzuki, Toshihiro
    Nosaka, Kazuto
    Shimizu, Hiroyasu
    Akazawa, Yu
    Charneau, Jimmy
    Sawada, Yu
    Endo, Itaru
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 276 - 276
  • [8] Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy
    Yao, Min
    Wang, Li
    Dong, Zhizhen
    Qian, Qi
    Shi, Yun
    Yu, Dandan
    Wang, Shiye
    Zheng, Wenjie
    Yao, Dengfu
    TUMOR BIOLOGY, 2014, 35 (06) : 5857 - 5868
  • [9] Glypican-3 as a serum marker for hepatocellular carcinoma
    Capurro, M
    Filmus, J
    CANCER RESEARCH, 2005, 65 (01) : 372 - 372
  • [10] Upregulation of Glypican-3 in Human Hepatocellular Carcinoma
    Beppu, Tetsuya
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junnichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Yamamoto, Norihiko
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    GASTROENTEROLOGY, 2012, 142 (05) : S972 - S972
12345